About GEN1E Lifesciences
GEN1E Lifesciences is a private company based in Palo Alto, California. It has reported $22,545,826 raised in two offerings on Form D since December 2022. Its chief executive is Soujanya Bhumkar.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2025 | Dec 29, 2025 | $5,520,803of $11.8M target | 44 | $125K | EquityRule 506(b) | Form D ↗ |
| Dec 6, 2022 | Dec 21, 2022 | $17,025,023of $18.2M target | 89 | $191K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $22,545,826 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GEN1E Lifesciences's Form D filed Dec 29, 2025.
RL
Ritu Lal
Executive officer and director
FN
Francois Nader
Director
AL
Alan Levy
Director
NK
Noor Kamruddin
Director
SB
Soujanya Bhumkar
Chief Executive Officer and director
Earlier filings also listed Dr. Alan Levy (director, last listed Dec 2022).